Background and Purpose: Stroke following percutaneous coronary intervention (PCI) is a
Introduction
Stroke is a serious complication following percutaneous coronary intervention (PCI).
We and others have previously shown that it is associated with high in-hospital mortality [1] [2] [3] [4] and causes life changing disabilities in those who survive [5] [6] [7] . Previous studies were conducted in both single centre [8] [9] and multicentre settings [1, 2] and reported the incidence, major determinants and outcomes of stroke following PCI.
PCI is performed either electively or in the setting of an acute coronary syndrome (ACS) as a non-elective (urgent/emergency) procedure. The clinical and procedural characteristics in these two settings are different [10, 11] , and it is conceivable that risk factors for stroke during these two clinical scenarios are likely to differ with different impacts on 30-day mortality and MACE (in-hospital major adverse cardiovascular events) associated with stroke. Indeed, Werner and colleagues have recently reported differences in determinants of stroke in different clinical settings but were unable to examine this issue specifically for ischemic and hemorrhagic stroke separately [2] . Better understanding of such determinants is important as these stroke subtypes have different pathophysiologies, different risk profiles and different survival trajectories [12] . These cannot be tested in randomised trial setting and such real world events needed to be observed and reported through registry data.
In this study, we examined the determinants and outcomes of ischemic and hemorrhagic stroke associated with PCI for ACS compared with those who underwent elective PCI using the British Cardiovascular Intervention Society registry in England and Wales including over half a million participants. The key objectives of the current study are therefore (1) to examine (a) the determinants and (b) factors associated with mortality and MACE following ischemic and hemorrhagic stroke following PCI in the ACS and elective settings separately; and (2) to compare the outcomes of the strokes following PCI between two clinical settings.
Methods
Data for the current study were taken from the British Cardiovascular Intervention Society (BCIS) dataset, which records all PCI procedures conducted in the UK. The data contains over 100 variables on clinical, procedural and outcome information with approximately ~80,000 new records added each year. In-hospital outcomes are recorded on the database and mortality outcomes tracked through the Medical Research Information Service (MRIS) using the patients' National Health Service number.
The main exposure variable for the analysis was whether the PCI procedure was carried out as an elective or for ACS. The main outcomes were in-hospital MACE and 30-day mortality associated with stroke following PCI. Major adverse cardiac events (MACE) were defined as a composite of in hospital mortality, myocardial infarction or repeat intervention.
We defined stroke-related mortality as mortality among patients who developed stroke complications after PCI. Other variables included as potential confounders are described in
Supplementary Data 1.

Statistical analysis
Statistical analyses were performed using Stata Version 13.0 (College Station, Texas, USA). Descriptive statistics were presented by indication (elective cases or PCI for acute coronary syndrome) and stroke subtype (ischemic and hemorrhagic stroke). Multiple imputations by chained equations were used to account for missing variables with 10 imputed datasets. All the non-outcome variables were then put into multiple logistic regression models to identify independent predictors of ischemic and hemorrhagic stroke subtypes separately according to indication of PCI. To calculate the impact of ischemic stroke and hemorrhagic stroke on in-hospital MACE and 30-day mortality, we used multiple logistic regressions controlled for all available covariates and executed separately for elective and ACS.
We then assessed the odds of these adverse outcomes in PCI for ACS using elective PCI procedure as the reference category in those who had stroke as a complication of PCI.
We used a step-wise modeling approach to better understand the associations and the following models were constructed. The models are described in Supplementary Data 1.
To account for baseline differences across stroke groups, multiple imputations with propensity score matching (mi estimate: teffects psmatch on Stata) was used to estimate the average treatment effect (ATE). The method was used to analyze two separate logistic treatment models (ischemic stroke vs. no stroke and any stroke vs. no stroke), calculating propensity scores for group membership. Additional descriptions of the analysis methods are described in Supplementary Data 1.
Results
A total of 588,636 patients underwent either elective PCI or PCI for ACS in England Supplementary Table 3 shows the results with logistic regression following propensity score matching. This analysis suggests a significant increase in in-hospital MACE for total and ischemic stroke in both settings. There were insufficient events to perform the propensity score matching analysis for hemorrhagic stroke. After propensity score matching, there were significant increases in in-hospital MACE for ischemic and any stroke following both PCI procedures. For 30-day mortality, similar significant increases were observed except for any stroke in elective patients.
Discussion
Our analysis of the UK national PCI database of over half a million patients undergoing PCI suggests that stroke is very uncommon after PCI. However, once stroke occurs as a complication of PCI, 30-day mortality and MACE are high, both in cerebral infarcts and hemorrhages. Surprisingly the odds of both these complications are higher following an elective procedure than for ACS, as patients with ACS are likely to be sicker and have a worse risk profile compared to elective patients. Patients undergoing elective PCI were usually treated with clopidogrel at the time of the procedure, while the majority of patients undergoing emergency PCI were more likely to be on newer oral antiplatelet therapies such as ticagralor and prasugrel and also be treated with glycoprotein IIb/IIIa inhibitors that have more potent anti-platelet inhibition properties. This could potentially have had a protective effect in relation to ischemic stroke but also increase the risk of death after intracerebral hemorrhage in the ACS group.
Our work provides insight to the outcomes associated with this rare but devastating complication of PCI to the stroke physician, who may not frequently encounter such patients frequently treated with potent anti-platelet and anti-coagulant therapies, which are necessitated during the PCI procedure. To our knowledge, this is the first paper to examine the determinants and outcomes of stroke following PCI by the indication as well as by specific stroke subtype. The key strength of our work is its large sample size and our ability to control for various potential confounders in an unselected cohort of patients undergoing PCI.
Our data builds on the report of Werner and colleagues who examined stroke risk stratified by the clinical setting of the PCI procedure [2] , by additionally demonstrating that risk factors for ischemic and hemorrhagic stroke also vary by the clinical setting of the PCI procedure. Cardiovascular risk factors appear to be major determinants of risk of developing ischemic stroke in ACS setting, whilst the stroke risk for elective PCI is associated with glycoprotein IIb/IIIa usage. This observation may relate to the fact that glycoprotein IIb/IIIa is used in higher thrombotic risk patients in the elective setting (such as diabetics or those patients undergoing complex procedures) who are at higher risk of sustaining ischemic events such as strokes [13, 14] . It is possible that use of these agents is a marker for the various procedural complications or complexities that led an operator to use these agents. Supporting the findings from TOTAL [15] , thrombectomy usage is also predictive of ischemic stroke after PCI for ACS. An important observation is the higher ischemic stroke risk observed for women for both indications for PCI (OR 2.62 and 1.78 respectively) compared to men.
It is interesting that age appears to be predictive of stroke complications only in ACS We found the risk of adverse outcome (in-hospital MACE or 30-day mortality) to be significantly higher in patients where PCI was complicated by a stroke regardless of stroke subtype or the clinical setting that it occurred in. Whilst this finding is not unexpected, we found that the greatest observed risk for adverse outcomes is associated with in-hospital strokes complicating elective PCI. This appears to be more pronounced in hemorrhagic stroke albeit with large estimates perhaps contributed by the relatively small sample size compared to ischemic stroke. Finally, once stroke has occurred, the further risk of MACE and 30-day mortality is high, but not significantly different between the two settings. Considering that patients with PCI have significant cardiovascular morbidity in addition to the stroke, it is not surprising.
Our study has several strengths. The BCIS dataset includes >95% of all PCI procedures performed in the UK which therefore reflects a national, real-world experience that includes high-risk patients encountered in daily interventional practice who are often excluded from randomized controlled trials. Whilst stroke is a relatively rare complication of PCI, its impact on mortality and morbidity and residual long-term disability has profound consequences not only for patients and their carers but also purchasers and providers of healthcare. Our large sample size allows us to study risk factors for sustaining a stroke complication following two clinical settings in which PCI is performed, as well as enabling us to compare and contrast the risk of adverse outcomes by the clinical setting and also provide stroke subtype specific prognostic information in these settings. This will enable stroke physicians to better counsel patients and their families regarding outcomes.
There are also limitations in this study. Our dataset does not capture the timing and severity of stroke, stroke nature and ADL score. We are unable to ascertain the temporal relationship between the predictor and stroke event. For example, it is possible that patients who undergo ventilation are more likely to develop stroke but patients might also be ventilated as a consequence of developing stroke or patients who were admitted with a myocardial infarction may have sustained a stroke as a consequence of the coronary event rather than the procedure itself. However, the primary focus is to compare and contrast risk factors and outcomes of each stroke subtype for each type of PCI procedure. As highlighted in our previous work [4] the diagnosis of stroke is reported by individual operators with no external validation, or information how the diagnosis was reached or what imaging modalities were used to ascertain etiology hence there is the potential for under-reporting or misclassification of neurological events. In the UK however, it is standard practice that anyone who sustains a stroke is referred to a stroke team who would organize the relevant neuroimaging, confirm the diagnosis and offer guidance in management of the patient.
Furthermore, our reported incident stroke rates are similar in magnitude to those reported in the national NCDR [2] and the SCAAR [16] datasets derived from USA and Sweden respectively. Given the smaller proportion of hemorrhagic strokes within the total stroke population in this cohort, even with over half a million PCI procedures, we were not able to perform propensity score matched analyses. Finally, whilst the BCIS dataset captures PCI related complications, it does not capture information as to how these were managed or whether there were differences in the management of such complications between units.
In summary, we found that stroke after both the elective and ACS setting is associated with adverse outcomes, irrespective of stroke subtype. Our study provides a better understanding of the risk factors as well as outcomes for stroke following PCI by procedure type as well as specific stroke subtype. This will inform both clinicians and patients on stroke risk associated in a specific PCI setting, but also provides important outcome information from a national perspective, to enable stroke physicians to counsel patients and their families around outcomes if such neurological complications occur, since stroke complications occurring in this setting will represent a small proportion of stroke physicians case mix.
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To account for baseline differences across stroke groups, multiple imputations with propensity score matching (mi estimate: teffects psmatch on Stata) was used to estimate the average treatment effect (ATE).
The method was used to analyze two separate logistic treatment models (ischemic stroke vs. no stroke and any stroke vs. no stroke), calculating propensity scores for group membership. Analysis for hemorrhagic stroke vs. no stroke was not possible because of too low propensity scores for many cases. Standard settings for the matching algorithm were used with a minimum of one neighbor requested for all observations and potential matches considered regardless of how dissimilar their propensity score. Tolerance for the overlap assumption was set to 10 -5 . We excluded variables which were perfect predictors from the propensity matching analysis. 
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